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Introduction Multiple pharmacokinetic (PK) studies have demonstrated that total body weight is the best method to dose vancomycin. However, clinicians usually prescribe the standard dose of antibiotic (1 g/12 h), independently of weight.
The aim of this study is to obtain the percentage of obese patients treated with vancomycin at the standard doses of 1 g/12 h with suboptimal serum concentrations. Materials & Methods Study conducted at 800-bed University General Hospital.
Observational study from July 2009 to May 2010 in (1) obese patients (BMI C 30 kg/m 2 ), (2) with creatinine clearance (Clcr) [50 ml/min and (3) monitored for vancomycin concentrations after the third dose of antibiotic (dosage: 1 g/12 h).
Individual PK parameters were estimated by assuming a bicompartmental PK model and Bayesian forecasting (PKS Ò Abbot Software). Afterwards, daily dose was adjusted to achieve a minimum vancomycin concentration at steady state (C min SS ) of 7-15 mg/l and a maximum vancomycin concentration at steady state (C max SS ) of 20-40 mg/l, in case of bacteraemia, or C min SS of 15-20 mg/l and C max SS of 30-40 mg/l, in case of meningitis, pneumonia, osteomyelitis, wound infection or abscesses. Data reviewed were: (1) demographics; (2) vancomycin serum concentrations withdraw 30 min before dose (C min SS ) and 2 h after ending antibiotic infusion (C max SS ) and (3) individual PK parameters. Results Ninety-one patients were recruited. Only 37 out of 91 patients fulfilled the inclusion criteria. Demographic data: 54% men (20 patients), age (mean ± SD) 62.8 ± 12.0 years, weight 95.9 ± 17.2 kg, BMI 35.2 ± 5.2 kg/m 2 , Clcr 70.1 ± 17.1 ml/min. Observed vancomycin serum concentrations after 3 doses of 1 g/12 h: mean C min SS 7.0 ± 3.3 mg/l, mean C max SS 16.4 ± 5.7 mg/l. Individual drug PK parameters (mean ± SD): steady-state volume of distribution 59.6 ± 13.4 l, total clearance 6.1 ± 2.0 l/h. Dose increase was needed in 27 patients (73.0%): 1,000 mg/6 h was set in 1 patient, 1,250 mg/8 h in 2 patients, 1,000 mg/8 h in 15 patients and 1,250 mg/12 h in 9 patients. Dose decrease to 750 mg/ 12 h was needed in 3 patients (8.1%). Six patients (16.2%) remained with the initial regimen, and in 1 case (2.7%), vancomycin was switched to linezolid because of Staphylococcus aureus methicillinresistant pneumonia. Discussion, Conclusion Results indicate that a high percentage of the patients included were underdosed (75.7%). Monitoring serum concentrations of antibiotic is necessary to adjust vancomycin dose to achieve therapeutic concentrations at the target infection site. 
